Highlights - Page 2
Pherecydes Pharma Present PHAGOBURN at Evergreen - 01/08/2013
The 20th Biennial Evergreen International Phage Meeting will take place at Evergreen (Olympia, WA, USA), from Aug. 4-9, 2013.
Dr. Jérôme Gabard will introduce the project PHAGOBURN: first european clinical study on phage therapy to treat E. coli and P. aeruginosa skin infections in burn wounds. A project supported by the European Union FP7.
Pherecydes Pharma secures DGA funding for evaluating the use of bacteriophages on infected burns. - 18/01/2012
The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
The full text of the press release is available by clicking on the following link.
Internet media coverage resulting from the announcement is available hereunder:
"Tough Microbe Infections" Forum - January 2012 - 11/01/2012
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Doctor Jérôme Larché, Président of PHAG ESPOIRS Association, has invited several patient associations and clinicians to discuss about antibiotic resistance and bacteriophage based treatments. The program of this free forum, open to the public, is dowloadable by clicking on the following link.